Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Esteve presents new calcium antagonists with potential as neuroprotectants

Dec. 1, 1997

Biological profile of the potent, selective dopamine D4 antagonist L-745870

Nov. 28, 1997

Results of large dose-finding study on rizatriptan in migraine reported

Nov. 28, 1997

Glutamate antagonists discovered at BASF

Nov. 28, 1997

The new frontier in medical research: prion diseases

Nov. 28, 1997

SmithKline Beecham and Cephalon terminate calpain inhibitor collaboration

Nov. 27, 1997

FDA clears Zomig

Nov. 27, 1997

Tolcapone reduces "wearing-off" phenomonen in Parkinson's disease patients

Nov. 27, 1997

SB-205384 associated with temporal modulation of GABA-gated currents

Nov. 27, 1997

Abbott improves on the pharmacological profiles of its ChCM candidates

Nov. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...